Hownaz Binavi, NP
Nurse Practitioner · San Diego, CANPI 1083276273
Payments from drug & device makers
Across 510 payments — averaging $19.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$1K
- AbbVie$1K
- Johnson & Johnson$1K
- Pfizer$712
- Sanofi$689
- Sun Pharmaceutical Industries Inc.$633
- plus $4K from 21 others
What the payments were for
- Food & beverage$9,27594%
- Education$5496%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 63 | $1,367 |
| AbbVie | 72 | $1,353 |
| Johnson & Johnson | 55 | $1,030 |
| Pfizer | 40 | $712 |
| Sanofi | 26 | $689 |
| Sun Pharmaceutical Industries Inc. | 36 | $633 |
| Regeneron Healthcare Solutions, Inc. | 17 | $505 |
| LEO Pharma Inc. | 44 | $502 |
| Lilly USA, LLC | 26 | $461 |
| Arcutis Biotherapeutics, Inc. | 28 | $426 |
| UCB, Inc. | 25 | $404 |
| Novartis | 15 | $327 |
| E.r. Squibb & Sons, L.L.C. | 15 | $302 |
| Amgen | 11 | $232 |
| Biofrontera Inc. | 6 | $231 |
| Galderma Laboratories, L.p. | 8 | $179 |
| Almirall LLC | 5 | $101 |
| Dermavant Sciences, Inc. | 4 | $84 |
| Boehringer Ingelheim | 3 | $75 |
| Botanix SB Inc | 2 | $49 |
| Journey Medical Corporation | 2 | $38 |
| Genentech USA, Inc. | 2 | $30 |
| Cipher Pharmaceuticals US LLC | 1 | $24 |
| Tactile Systems Technology Inc | 1 | $22 |
| LNHC, Inc | 1 | $20 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $13 |
| Verrica Pharmaceuticals Inc. | 1 | $13 |
How this compares
$9,824 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $67,285 |
| Clobetasol Propionate | 63 | $2,656 |
| Fluorouracil | 20 | $937 |
| Doxycycline Hyclate | 54 | $672 |
| Triamcinolone Acetonide | 58 | $621 |
| Betamethasone Dipropionate | 16 | $588 |
| Ketoconazole | 41 | $571 |
| Imiquimod | 11 | $269 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in San Diego
- Angelina CollinsSan Diego$356K
- Madison ShreeveSan Diego$310K
- Arlene OrtegaSan Diego$135K
- Stacey RossSan Diego$43K
- Timothy LazarekSan Diego$37K
- Melanie McGillowaySan Diego$33K
- Jeremy FlowersSan Diego$26K
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.